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Abstract

CHARACTERIZATION OF THE EXPRESSION OF THE INTERCELLULAR
ADHESIN LOCUS IN STAPHYLOCOCCUS AUREUS
By: Jamie L. Brooks, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University
2012
Major Director: Kimberly K. Jefferson, Ph.D.
Associate Professor, Department of Microbiology and Immunology

Poly-N-acetylglucosamine (PNAG) is an important Staphylococcus aureus
virulence factor. It is a major component of the extracellular polymeric matrix in biofilms,
and contributes to resistance to the innate immune response. The proteins encoded in the
icaADBC (intercellular adhesin) operon are responsible for PNAG production. Here, we
present evidence of a new mechanism of phase variation for switching off PNAG
production that involves slipped strand mutagenesis, along with further insight into the
regulation and expression of the icaADBC operon. S. aureus strain MN8m (mucoid) is a

spontaneous mutant of strain MN8 (non-mucoid). It is characterized by constitutive
overproduction of PNAG, resulting from a 5 bp deletion in the icaADBC promoter region.
First, we explored the effect of this mutation on the binding of the positive regulator SarA
and its regulation of icaADBC in MN8m; and demonstrated that while binding is not
inhibited by the MN8m promoter mutation, it appears that SarA exhibits a negative
influence on transcriptional activation in this strain background. Second, we found that
non-mucoid mutants were frequently detected in MN8m cultures. The PNAG mutants still
exhibited elevated icaADBC transcript levels and the 5 bp deletion was still present, but
they were PNAG-negative. The most frequent mutation responsible for the phenotype
was a slipped strand mispairing in the icaC gene. We found that, in vitro, PNAG-negative
mutants had a growth advantage and increased fitness relative to the mucoid, PNAGoverproducing strain. Therefore, the slipped strand mutants in the PNAG-off state had a
competitive growth advantage and eventually predominated the culture. Reversion back
to mucoid occurred but revertants were isolated infrequently, due to their compromised
fitness. The region of slipped strand mispairing was found to vary in several clinical S.
aureus isolates, indicating in vivo relevance of this new mechanism. Third, a non-mucoid
variant was isolated with the same phenotype and growth properties that instead had a
nonsense mutation in icaB, which has demonstrated that there is a polar translational
relationship between icaB and icaC. Together, these studies have given us insight into
the regulation and expression of icaADBC expression and have revealed a growth
disadvantage associated with PNAG overproduction.
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CHAPTER 1
Introduction

Clinical Significance of Staphylococcus aureus

Staphylococcal bacteria are Gram-positive cocci that are part of the family
Staphylococcaceae in the order Bacillales. The staphylococci are non-motile, non-spore
forming facultative anaerobes, capable of growth by either aerobic respiration or
fermentation. Staphylococci are oxidase negative and predominantly catalase positive,
allowing them to be distinguished from streptococci. Staphylococcus aureus and
Staphylococcus epidermidis are the most studied and well-characterized species of the
genus. Staphylococcus aureus is of particular clinical importance because it is a major
opportunistic pathogen responsible for a large range of infections that contribute
significantly to morbidity, mortality and healthcare costs. It can be found commensally
on mucosal surfaces such as the anterior nares, and transiently on the skin. S. aureus
is a leading cause of nosocomial infections, particularly on indwelling medical devices.
Infections occur when the bacteria cross the epithelial boundary, where they are
capable of infecting a wide variety of body tissues. Mild soft tissue skin infections
caused by S. aureus such as impetigo and foliculitis are generally self-limiting.
However, more severe life-threatening infections including osteomyelitis, bacteremia,
toxic shock syndrome, necrotizing pneumonia and infective endocarditis are commonly
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caused by S. aureus. In fact, in the United States and Canada, S. aureus is the most
common cause of skin/soft tissue infection, bacteremia, and nosocomial lower
respiratory tract infections (Diekema et al., 2001). Additionally, deaths from methicillin
resistant S. aureus (MRSA) alone exceed 18,000 yearly in the United States, making it
the leading cause of death by a single infectious agent (DeLeo & Chambers, 2009).
Treatment of S. aureus infections is complicated by its tendency to acquire resistance to
the antibiotics commonly used to combat infection, quickly becoming multi-drug
resistant. Oxacillin/methicillin resistance (MRSA) is widespread in both hospital and
community settings, with numerous vancomycin resistant (VRSA) strains already
emerging as well (DeLeo & Chambers, 2009, Howden et al., 2010). In 2010, S. aureus
was reported to have acquired resistance to some of the newest antibiotics approved as
last resorts for treatment, daptomycin and linezolid (Nannini et al., 2010). S. aureus
expresses an arsenal of virulence factors that allow it to establish infection and survive
challenge. It can produce proteins and polysaccharides that inhibit complement and
opsonization, as well as toxins, proteases, and superantigens (Foster, 2005). S. aureus
also encodes various adhesion proteins/polysaccharides, and its ability to form a
hardy/adherent biofilm can contribute to virulence. This proficient biofilm formation is
associated with medical implant infections, although biofilm-associated infections can
also be associated with host tissue. Examples of staphylococcal biofilm-associated
infections include but are not limited to chronic rhinosinusitis, acute septic arthritis,
endophthalmitis, chronic bacterial prostatitis, and native-valve endocarditis.
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Biofilms

A biofilm is an aggregation of sessile bacteria that are encased in a
predominantly self-produced extracellular polymeric substance/matrix (EPS) that holds
them together and onto a surface. The extracellular polymeric matrix can be composed
of bacterial proteinaceous adhesins, teichoic acids, extracellular DNA, and/or
polysaccharides (Cucarella et al., 2001, Izano et al., 2008, Gross et al., 2001). The ratio
of these different EPS components is highly variable, changing in response to various
stimuli; and can vary between different sites of infection or within a single biofilm at
different points in time. The exact process of biofilm formation is difficult to define since
different environmental conditions and bacterial genetic backgrounds can influence the
function of numerous regulators, adhesins, and enzymes, causing a large degree of
variation in physical characteristics. Cell-cell communication (quorum sensing) is
optimized within a biofilm, since cells are held together closely, permitting coordinated
gene expression and maturation of the biofilm over time (Davies et al., 1998).
Initial adherence of planktonic bacteria to a surface begins the process of biofilm
growth, when cells begin deposition of the EPS molecules encouraging intercellular
aggregation. As a biofilm matures it develops a distinct physical architecture to maintain
hydration and the flow of nutrients to the resident bacteria that is characterized by
tower-like structures interspersed with fluid-filled channels (Costerton et al., 1995). As a
biofilm becomes fully mature, individual planktonic cells or small clumps of intact biofilm
may be dispersed into the surrounding environment to seed new sites of infection.
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The biofilm mode of growth confers several different survival advantages on the
resident bacteria, including a high degree of resistance to environmental forces like UV
light, sheer force, and desiccation. The biofilm is also capable of shielding cells from the
host immune response (Vuong et al., 2004b) and challenge with numerous different
types of antibiotics. In fact, biofilm bacteria are able to withstand antibiotic
concentrations up to 1000-fold higher than their genetically identical planktonic
counterparts (Hoyle & Costerton, 1991). Several different aspects of biofilm formation
have been suggested to contribute to these significant survival advantages. Biofilms are
organized into different regions of altered metabolic activity based upon the availability
of nutrients and external stimuli. Bacteria tend to become less aerobic and growth is
slowed as proximity from the edges of the biofilm diminish, resulting in a sub-population
of cells that are intrinsically resistant to antibiotics that depend on active cellular growth
for their mode of killing (Brown et al., 1988). This resistance effect is heightened by the
extrapolymeric matrix surrounding the cells within a biofilm. The EPS molecules at the
biofilms exterior perimeter may slow penetration of a certain antimicrobials through
electrostatic properties or size/physical properties, depleting the local lethal
concentration and/or allowing more time for cells further within the biofilm to react
(Vuong et al., 2004b, Walters et al., 2003). Additionally, recent evidence points to
increased concentration of a sub-population of persister cells within biofilms (Keren et
al., 2004). Persister cells are dormant cells that are highly tolerant to a variety of
antibiotics, and they are capable of reestablishing a biofilm infection after even
extremely high concentrations of antimicrobials that have been applied are removed,
complicating complete eradication of a biofilm infection and leading to relapse. Biofilm-
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mediated resistance is a phenotypic trait, and if an established biofilm can be
successfully dispersed the bacteria regain planktonic levels of sensitivity to antibiotics
and to host immune defenses.

Staphylococcal Biofilms
A wide variety of extracellular adhesive matrix components have been identified
as mediators of staphylococcal biofilms. Extracellular DNA, either derived from lysed
bacteria or potentially from other sources (such as DNA released by neutrophils during
host immune response), has been shown to be a major component of staphylococcal
biofilm extracellular matrix, particularly in S. aureus biofilms (Izano et al., 2008).
Staphylococcus aureus also expresses a large variety of surface-associated
proteinaceous adhesins that can contribute to the composition of the EPS. Additionally,
other surface expressed proteins can play a role, including different MSCRAMMs
(microbial surface components recognizing adhesive matrix molecules), such as
fibronectin-binding proteins (FnbpA, FnbpB), collagen-binding protein, clumping factors
(ClfB), and SasG. Polysaccharide adhesins can also mediate biofilm formation, and one
of the most prominent and well-characterized adhesive molecules in S. aureus
infections is the polysaccharide poly-N-acetylglucosamine.

icaADBC and Poly-N-acetylglucosamine
A major component of the S. aureus biofilm extracellular matrix, and an important
virulence determinant in S. aureus infections in general, is the polysaccharide poly-Nacetylglucosamine. Poly-N-acetylglucosamine (PNAG), also referred to as
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polysaccharide intercellular adhesin (PIA) in S. epidermidis, is a high molecular weight
polymer of β-1-6-linked N-acetyl-glucosamine (Mack et al., 1996, Maira-Litran et al.,
2002). In addition to its role in intercellular adhesion and biofilm formation, PNAG also
plays a role in immune evasion (Cerca et al., 2007, McKenney et al., 1998). PNAG is
synthesized by the proteins encoded in the icaADBC intercellular adhesin locus (Fig. 1
& 2). IcaA is a transmembrane glucosyltransferase that, together with IcaD, produces
short PNAG oligomers (Gerke et al., 1998). IcaC is an integral membrane protein that is
necessary for linking the short oligomers into longer polymer chains, and is thought to
be involved in translocation of these chains to the cell surface (Gerke et al., 1998).
Once there, IcaB is responsible for partial deacetylation of the PNAG molecule, which is
required for retention at the cell surface (Vuong et al., 2004a). There are multiple known
regulators of the ica locus. The icaR gene is located upstream of the icaADBC operon.
It is a direct transcriptional repressor that is divergently transcribed from the rest of the
operon. CodY has also been demonstrated to act as a negative transcriptional regulator
(Majerczyk et al., 2008). The S. aureus global regulator SarA is an important positive
regulator of ica that has been shown to bind in and around its promoter region (Tormo
et al., 2005).
Staphylococcus aureus strain MN8m
S. aureus strain MN8m has proven to be a useful tool for investigating the role of
PNAG is biofilm formation, due to its defining characteristic as a PNAG over-producing
strain. MN8m was originally isolated as a spontaneous mutant by virtue of its mucoid
phenotype from a chemostat culture of strain MN8, a toxic shock syndrome clinical
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isolate (Cramton et al., 1999). The mutation that conferred this PNAG-overexpression,
or the mucoid phenotype, was identified as a 5-bp deletion in the icaADBC promoter
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Figure 1: Organization of the icaADBC operon. The Ica proteins are encoded by the
icaADBC locus, which includes the divergently transcribed icaR gene.
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Figure 2: Roles of IcaADBC in PNAG synthesis. The exopolysaccharide poly-Nacetylglucosamine (PNAG) is synthesized by the Ica proteins. (1) IcaA, a
transmembrane glucosyltransferase, assembles short PNAG oligomers in conjunction
with the IcaD membrane protein. (2) The PNAG precursors are then assembled into
growing polymer chains by the transmembrane protein IcaC, which is thought to then
translocate them to the cell surface. (3) IcaB is located on the cell surface and is
responsible for partial deacetylation of the PNAG molecule, introducing random
positively charged regions to the polymer, allowing it to be surface retained.
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Figure 3. Schematic representation of the promoter region of the MN8 ica operon.
Promoter elements, effector binding sites, and transcriptional start sites (TSS) are
labeled. The five nucleotides underlined in purple at the TSS of icaR represent the 5 bp
deleted in the mutation from MN8 to MN8m, previously identified as responsible for the
conversion.
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region (Jefferson et al., 2003) (Fig. 3). The mutation leads to constitutive icaADBC
transcription, but the molecular basis for this overexpression has not been defined.
Preliminary evidence shows that the effect is not mediated by interference of the
deletion with the transcriptional start site of the divergently transcribed negative
regulator IcaR, since the complete absence of icaR does not stimulate icaADBC
transcription to the extent that is observed in strain MN8m.

Research Objectives

Staphylococcus aureus infections are of particularly important clinical
significance due their widespread nature, enormous expense associated with treatment,
and high morbidity and mortality. The ability of S. aureus to rapidly develop antibiotic
resistance has led to the pursuit of alternative therapeutic approaches. Recent
recognition of the major role that biofilm formation plays in many S. aureus infections
has made it a major target of interest for new treatment development. Many of the
proposed anti-biofilm therapies focus on inhibition, reversal, or dispersal of the biofilm
phenotype by targeting the extracellular polymeric matrix. In order for this to be a viable
new approach to treatment, our understanding of how the adhesive molecules that
make up the EPS matrix are regulated, must be expanded and improved. Although the
role of PNAG in S. aureus biofilms as an adhesin has been well established, our
knowledge about its regulation remains incomplete. The goal of this project is to utilize a
strain that over-produces PNAG to better elucidate details of the expression and
regulation of the icaADBC operon responsible for PNAG synthesis. First, to better
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understand promoter-regulator interactions and promoter characteristics that influence
transcriptional activation. Secondly, to explore new evidence that PNAG expression can
be modulated by phase variation within a biofilm population to reduce its contribution.
These objectives have resulted in characterization of a novel form of phase variation
PNAG that suggests a potential for roles of the icaADBC genes beyond PNAG
synthesis, and the realization of a previously unknown polar relationship between genes
of the operon. This study also provides new insight into the role of SarA in icaADBC
activation, and further characterization of the molecular mechanism responsible for
over-production of PNAG in S. aureus strain MN8m.
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CHAPTER 2
Materials and Methods

Staphylococcal strains and culture conditions. Bacterial strains used in these studies
are listed in Table 1. Staphylococcus aureus strains were grown aerobically at 37°C on
tryptic soy agar (TSA) plates containing the appropriate antibiotic. Liquid cultures were
in tryptic soy broth containing 1% glucose (TSBG), incubated aerobically at 37°C, 200
rpm. Congo red agar, used to asses mucoid phenotype by colony morphology, was
composed of brain heart infusion (BHI) agar + 3.6% sucrose + 0.5% glucose + 0.08%
Congo red. Escherichia coli strains were grown aerobically at 37°C on Luria-Bertani
broth (LB) agar plates containing the appropriate antibiotic. E. coli liquid cultures were in
LB, incubated aerobically at 37°C, 200 rpm. Appropriate antibiotics were incorporated at
the following concentrations: 100 µg/ml ampicillin (Amp) for E. coli, 35 µg/ml
chloramphenicol (Cm) for E. coli, 10 µg/ml Cm for S. aureus, 5 µg/ml tetracycline (Tet)
for S. aureus, and 10 µg/ml erythromycin (Erm) for S. aureus.

Agarose gels. 1.0% agarose gels were prepared by dissolving agarose in 1X Trisacetate-EDTA (TAE) buffer (Fisher Scientific, Pittsburg, PA), with 0.15 µg/mL ethidium
bromide added before pouring. 10X BlueJuice loading buffer (Invitrogen, Grand Island,
NY) was added to DNA samples to achieve a 1X final concentration. Gels were run
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Table 1. Bacterial strains
S. aureus Strains
MN8

MN8∆ica::tet

Description

Source

Nonmenstrual toxic shock syndrome
clinical isolate

(Schlievert &
Blomster, 1983)

icaRADBC mutant of S. aureus MN8
r
(Tet )

(Jefferson et al.,

r

2003)

MN8∆sarA::erm

sarA mutant of S. aureus MN8 (Erm )

Jefferson lab strain

MN8m

Spontaneous mucoid mutant isolated
from a chemostat culture of S. aureus
MN8

(Cramton et al.,
1999)

JB12

Spontaneous non-mucoid mutant
isolated from a chemostat culture of S.
aureus MN8m

This study

JB12 + pCL15

Complementation of JB12 with pCL15
r
(Cm , empty vector)

This study

JB12 +pCL15-icaC

Complementation of JB12 with icaC
r
from MN8m in trans using pCL15 (Cm )
Primers: icaCSphIFwd, icaCKpnIRev

This study

JB17

Spontaneous non-mucoid mutant
isolated from a chemostat culture of S.
aureus MN8m

This study

JB17 + pCL15

Complementation of JB17 with pCL15
r
(Cm , empty vector)

This study

JB17 + pCL15-icaB

Complementation of JB17 with icaB
r
from MN8m in trans using pCL15 (Cm )
Primers: icaBBamHIFwd,icaBEcoRIRev

This study

JB17 + pCL15-icaC (native)

Complementation of JB17 with icaC
r
from MN8m in trans using pCL15 (Cm )
Primers: icaCSphIFwd, icaCKpnIRev

This study

JB17 + pCL15-icaC (ideal)

Complementation of JB17 with icaC
from MN8m with a modified ribosomal
r
binding site, in trans using pCL15 (Cm )
Primers: icaCRBSFwd, icaKpnIRev

This study
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JB17 + pCL15-icaBC

Complementation of JB17 with icaBC
r
from MN8m in trans using pCL15 (Cm )
Primers: icaBSphIFwd, icaCKpnIRev

This study

ALC1342∆sarA::erm

sarA mutant of S. aureus RN6390
r
(Erm )

(Cheung & Manna,
2005)

RN4220

Restriction defective derivative of S.
aureus RN450

(Kreiswirth et al.,
1983)

RN4220∆ica::tet

icaRADBC mutant of S. aureus RN4220
r
(Tet )

Jefferson lab strain

RN4220∆ica::tet + pBT9-M1

Complementation of RN4220 icaADBC
mutant with icaRADBC from MN8m in
r
r
trans using pBT9 (Tet , Cm )

This study

RN4220∆ica::tet ∆sarA::erm

Complementation of RN4220 sarA and
icaRADBC mutant with icaRADBC from
r
r
MN8m in trans using pBT9 (Tet , Cm )

This study

+ pBT9-M1

E. coli Strains

Description

Source

CH3 Blue

Chemically competent cells derived from
r
E. coli K12, cloning strain (Amp when
transformed with plasmid)

Bioline (Tauton, MA)

BL21-CodonPlus(DE3)-RIL

Chemically competent cells derived from
E. coli BL21, heterologous protein
r
expression strain (Amp when
r
transformed with plasmid, Cm )

Stratagene (La Jolla,
CA)

BL21 + pET32xT-sarA

BL21-CodonPlus(DE3)-RIL cells
containing sarA from MN8 in trans using
r
r
pET32xT (Amp , Cm )

This study
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at 125 volts in 1X TAE buffer and visualized under UV light. DNA size was determined
by comparison against the Hyperladder series of DNA molecular weight markers
(Bioline, Taunton, MA).

Biofilm growth assay. Microtiter plate assays for biofilm formation were performed
essentially as described previously by Christensen et al. (1985) with minor
modifications. Cultures were grown overnight in 4 ml of TSBG or TSBG + 10 µg
chloramphenicol/ml, diluted 1:200 in the same media or media with 1mM IPTG added
for plasmid induction, and aliquoted into 96-well polystyrene flat-bottom microtiter plates
(Greiner Bio-One, Monroe, N. Carolina). After 24 hours at 37°C, the wells were emptied
and washed once with phosphate-buffered saline (PBS). The plates were dried at room
temperature, stained with 200 µl safranin for 1 minute, washed gently with water, and
allowed to dry. The biofilms were assessed qualitatively by visual inspection and images
were taken using a digital scanner. The safranin was then resuspended in 200 µl 33%
acetic acid and the wells were analyzed by spectrophotometry at OD562 nm using a 96well plate spectrophotometer.

Planktonic growth assay. To generate a bacterial growth curve, cultures were grown
overnight in TSBG, and gently sonicated for 30 seconds. Each culture was diluted to
OD600nm of 0.1 and used to inoculate fresh TSBG 1:100, with separate tubes for each
time point. The cultures were incubated at 37°C, 200 rpm. At each time point the
cultures were gently sonicated, the OD600nm measured, and then serially diluted and
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plated in triplicate on TSA plates to determine the number of colony forming units
(CFU).

gDNA extraction. To isolate genomic DNA, bacteria were grown overnight in liquid
cultures, diluted to OD600nm = 1.0 in 1 ml total volume, and collected by centrifugation.
The bacterial pellets were resuspended in 180 µl of lysis buffer, composed of 2.4 µl
Triton X-100, 10 µl 5 mg/ml lysostaphin, and 20 mg lysozyme in 190 µl 1X TE buffer (10
mM Tris-HCl pH 7.5, 1 mM EDTA); and incubated for 30 minutes at 37°C. The Qiagen
DNeasy Blood and Tissue kit (Qiagen, Valencia, CA) was used from this point to extract
the gDNA. Samples were incubated with 25 µl proteinase K and 200 µl Buffer AL at
56°C for 30 min, and 200 µl 100% ethanol added. The mixture was transferred to
DNeasy Mini spin column, centrifuged at max speed for 1 minute, and the column was
then washed with 500 µl Buffer AW1. After repeating centrifugation, 500 µl Buffer AW2
was added and the column dried by centrifugation at max speed for 3 minutes. gDNA
was eluted by application of 200 µl sterile water directly to the column membrane,
followed by centrifugation for 1 minute.

Polymerase chain reaction (PCR) and product purification. Similar general conditions
were used for all PCR amplification of DNA with slight modifications dependent on the
DNA template to be used, product size, or the melting temperature (TM) of the primer
set. Reaction mixtures were typically 50 µl total volume composed of 10 µl 5X Phire
buffer (Thermo Scientific, Waltham, MA), 1.5 µl 10mM dNTPS (2.5 mM of each), 10
pmol of both the forward and reverse primers, DNA template and 1 µl Phire II
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polymerase in sterile water. For reactions using gDNA as template 3 µl was added;
whereas only 1 µl was used for reactions based on plasmid DNA or DNA products
purified from previous PCR’s. Template material for colony PCR was obtained by
resuspended a single colony in 10 µl sterile water, and using 3 µl of the mixture for the
reaction. Reaction conditions were programmed into a thermal cycler machine as: hot
start at 105°C, initial denaturation at 95°C for 2 minutes, followed by 35 cycles of 94°C
for 30 seconds, TM + 3°C of the lower primer TM for 30 seconds, and 72°C for 15
seconds per kb of expected product size, and a round of final extension at 72°C for 10
minutes. PCR products were purified after electrophoresis in agarose gel using the
QIAquick Gel Extraction kit (Qiagen, Valencia, CA) as described by the manufacturer.

Plasmid DNA purification and manipulation. Plasmid purifications were performed using
the QIAprep Spin Miniprep kit (Qiagen, Valencia, CA) according to the manufacturer’s
instructions, from overnight cultures of E. coli single colony transformants in 3 ml LB
with ampicillin. All restriction enzymes, specific buffers, and BSA used for restriction
enzyme digests of plasmid DNA or PCR products were purchased from New England
Biolabs (Ipswich, MA), and used according to the manufacturer’s recommendations.
After plasmid restriction digestion, the 5’ phosphoryl groups were removed using
Antarctic Phosphatase and its supplied buffer (New England Biolabs, Ipswich, MA)
according to manufacturer’s instruction, to prevent re-ligation. Ligation of DNA fragment
inserts into digested plasmids was accomplished using Ready-To-Go T4 DNA Ligase
and Ligase Buffer (Amersham Biosciences, Piscataway, NJ) at roughly a 3:1 ratio of
insert to plasmid, at 16°C for a minimum of 1 hour.
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Table 2. Primer List
Primer Name

Sequence

icaseq1

5’-CAAGTGTTGTACCGTCATACC-3’

icaseq2

5’-CGTCGATTTACAAGAAAACAGAGG-3’

icaseq3

5’-AGGTCTTTGGAAGCAACGCG-3’

icaseq4

5’-ATCGCTATATCTTGTGTCTTTTGG-3’

icaseq5

5’-AAATGGCTAAAATCACATGATGC-3’

icaseq6

5’-TACCGGTAATCAAAAAAGCTGGG-3’

icaseq7

5’-GTCCTATTAGGTCAATGGTATGG-3’

icaseq8

5’-GAGGATAATACAATGGTCTTTCTAGC-3’

icaseq9

5’-CACTCCCATTGGCATTTACGAAG-3’

icaseq10

5’-CCAATAGTCTCCATTTGCTAACGC-3’

icaseq11

5’-ACGCGTGTAGTTAAGTATCTATAGG-3’

icaseq12

5’-GATAAGTTATGCAAATCGTGGGTATG-3’

icaseq13

5’-ACCATCCAGTGTGCTTACAGG-3’

icaseq14

5’-GCGACTATCAATAAAGAGTGCGACTG-3’

icaseq16

5’-CCAGCAAGTGTCTGACTTCG-3’

icaseq16

5’-CATCCACATTTATGTCAGGCTTC-3’

sarAFwd

5’-CGCGGATCCGCAATTACAAAAATCAATGATT-3’

sarARev

5’-GGGCTCGAGTTATAGTTCAATTTCGTTGTT-3’

icaBBamHIFwd

5’-CCGCGGATCCCAAAAATGGCAGAGAGGAAGA-3’

icaBEcoRIRev

5’-CCGCGAATTCAGCACGTAAATATACGAGTTCAAGT-3’

icaBSphIFwd

5’CCGCGCATGCCAAAAATGGCAGAGAGGAAGA-3’

icaCSphIFwd

5’-CCGCGCATGCCAAAAATGGCAGAGAGGAAGA-3’

icaCKpn1Rev

5’-CCGCGGTACCCCGCGTGTTTTTAACATAGC-3’

icaCRBSFwd (SphI)

5’-CCGCGCATGCGAGCATTTAATTAAGAGATGAGGAGGATTC-3’
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16SRTFwd

5’- TATGCATCGTTGCCTTGGTA-3’

16SRTRev

5’-GAACCGCATGGTTCAAAAGT-3’

icaCRTFwd

5’-CGAACAACACAGCGTTTCAC-3’

icaCRTRev

5’-CGTTCCAATAGTCTCCATTTGC-3’

icaRRTFwd

5’-TTTGTAATTGCAACTTAATTTTCCTG-3’

icaRRTRev

5’-AAACAACATTTAACACTTTGTTCGT-3’

sarARTFwd

5’-TTGCTTTGAGTTGTTATCAATGG-3’

sarARTRev

5’-TTTCTCTTTGTTTTCGCTGATG-3’

icaProBTFwd

5’-TGTTACAGGAAAATTAAGTTGCAATTACA-3’

icaProBTRev-BioTEG

5’-GGTTGTAAGCCATATGGTAATTGATAGT-3’

icaProBend1-Xba

5’-TCTAGACTATGTTACAGGAAAATTAAGTTGC-3’

icaProBend2-Sal

5’-GTCGACGATAGTATTTTAATTTGCAATAGATTGTTG-3’
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Transformation of chemically competent E. coli. One vial of chemically competent E. coli
cells was thawed on ice; 4 µl of plasmid ligation reaction was gently added and
incubated on ice for 30 minutes. The tube was transferred to a 42°C water bath for 30
seconds, and placed back on ice until 200 µl SOC media (85.5 mM NaCl, 2.5 mM KCl,
10 mM MgCl2, 2% tryptone, 0.5% yeast extract, and 20mM glucose) could be added.
The cells were allowed to recover at 37°C for 1 hour, and then plated on LB plates with
appropriate antibiotic selection.

Production of electrocompetent S. aureus RN4220. Overnight cultures of S. aureus
RN4220 were grown shaking in TSB at 37°C, 200 rpm. The bacteria were subcultured
by 1:100 dilution in fresh TSB, and grown to exponential phase (OD600nm = 0.5 to 0.8) at
37°C, 200 rpm. Cell pellets were obtained by centrifugation for 15 minutes at 4°C, 4000
rpm. All subsequent steps were carried out on ice, with pre-chilled reagents. The pellet
was washed three times with 25 ml of ice cold sterile water, using 5 minute
centrifugations to re-pellet cells in between washes. The pellet was then washed a final
time in 30 ml cold 10% glycerol in water, before being resuspended in 15 ml 10%
glycerol and incubated at room temperature for 15 minutes. The cells were then again
collected by centrifugation, and the final pellet resuspended in 500 µl 10% glycerol.
Aliquots (50 µl) were stored at -80°C until use.

Transformation of electrocompetent S. aureus. One vial of electrocompetent S. aureus
RN4220 cells was thawed on ice; 5 µl plasmid DNA was gently added and incubated on
ice for 30 minutes. The mixture was then transferred to an electroporation cuvette with a
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gap length of 0.1 cm and pulsed once using the Micropulser machine (Bio-Rad,
Hercules, CA) pre-set S. aureus setting (1.8 kV, 2.5 msec, 25 µF). Immediately
following electroporation, 500 µl of TSB containing the appropriate antibiotic (diluted
1:500 from normal liquid culture concentration to a sub-inhibitory concentration) was
added and the entire mixture transferred to a culture tube. The cells were allowed to
recover at 37°C for 2 hours, and then plated on TSA plates with appropriate antibiotic
and incubated overnight at 30°C.

Phage transduction. The generalized transducing phage 80𝛼 was used to create allelic
exchange mutants or to move plasmids between S. aureus strains. The donor strain
was scraped from an overnight plate into 250 µl TSB until extremely turbid, which was
then added to 0.4% soft TSA containing 5 µl of 2 M CaCl2. After addition of 75 µl of
phage 80𝛼, the mixture was poured onto a TSA plate and incubated at 37°C until lysis
occurred, indicated by clearing of the top agar. Following lysis, the soft top agar was
collected, centrifuged, and the supernatant filter sterilized using a 0.45 µm syringe filter.
The recipient strain was scraped from an overnight plate into 300 µl TSB until extremely
turbid, and was divided into three 100 µl culture tubes containing 2.5 µl of 2 M calcium
chloride each. Aliquots of the phage lysate, either 75 µl, 150 µl, or 250 µl were added to
each of the tubes and the total volumes brought up to 2 ml with TSB. The mixtures were
incubated shaking at 37°C for exactly 20 minutes, and 3 ml of 20 mM sodium citrate
added. After centrifugation to collect the bacteria, the pellet was resuspended in 3 ml
sodium citrate again and centrifuged. The remaining pellet was resuspended in 500 µl
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20 mM sodium citrate, incubated at 37°C for 2 hours, and then plated on TSA
containing the appropriate antibiotic to be incubated for 48 hours at 37°C.

RNA isolation. Overnight liquid cultures were diluted 1:10 in 5 ml TSBG and incubated
shaking for 4 hours at 37°C. The bacteria were collected by centrifugation and stored at
-80°C, for a minimum of 1 hour or until use. RNA was extracted using the Qiagen
RNeasy Mini kit (Qiagen, Valencia, CA) with some modifications. The pellets were
resuspended in 500 µl Buffer RLT and transferred to 2 ml tubes containing 1mm glass
beads (Research Products International Corp., Mount Prospect, IL). After adding 500 µl
cold acid phenol, the cells were lysed twice using a FastPrep FP120 (Thermo,
Pittsburgh, PA) at a speed setting of 6.0 for 40 seconds, cooling the tubes on ice for 5
minutes between the runs. The aqueous phase was collected after centrifugation and
mixed with 500 µl 100% ethanol. Samples were applied to an RNeasy spin column, and
following manufacturer’s instructions, the column was washed once with 700 µl Buffer
RW1 and twice with 500 µl Buffer RPE. The columns were dried by centrifugation at
max speed for 3 minutes and the RNA eluted in 90 µl sterile, nuclease-free water.
Contaminating DNA was digested with Turbo DNase (Ambion, Austin, TX) with the
accompanying buffer for 1 hour at 37°C. The DNase was inactivated and removed using
DNase Inactivation Reagent (Ambion) according to manufacturer’s directions.
Absorbance was measured at 260 nm and 280 nm using a NanoDrop 10000 (Thermo
Scientific, Waltham, MA), and the ratio of the two values was used to calculate the
concentration of RNA.
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cDNA synthesis. cDNA was synthesized from 1 µg of isolated mRNA by a two-step
reverse transcription reaction using the Bioline Tetro cDNA synthesis kit (Bioline,
Tauton, MA) according to manufacturer’s directions. The RNA was mixed with 10 pmol
of up to six gene-specific reverse primers in 10 µl total volume, and incubated at 70°C
for 10 minutes. 1 µl of 10mM dNTPs (2.5 mM of each), 1 µl RNase inhibitor, 4 µl 5X RT
buffer, and 1 µl reverse transcriptase in 10 µl total volume was added to the RNA +
primer mix. This was followed by incubation for 2 hours at 42°C, and 70°C for 15
minutes. Control reactions (noRT) contained only RNA and water.

Real-time RT-PCR. cDNA synthesized from isolated mRNA, or the noRT control, was
diluted 1:10 in water for use with gene-specific primers, and 1:1000 for 16S reactions.
The reaction mix was composed of 2 µl of the diluted cDNA, 10 pmol of both the forward
and reverse primers, 8.5 µl sterile water, and 12.5 µl SYBER Green Sensimix (Bioline,
Tauton, MA). Real-time RT-PCR was performed in a iQ5 Multicolor Realtime PCR
Detection system (BioRad, Hercules, CA) following the programmed steps: 1 cycle of 3
minutes at 95°C, 40 cycles of 20 seconds at 95°C, 20 seconds at 55.2°C, 20 seconds at
72°C while collecting real time-PCR readings, and 41 cycles of 30 seconds at 55°C
while collecting melting curve readings. Data was recorded in cycle threshold (Ct) for
each sample in technical triplicate, and normalized to the 16S transcript level by
calculating 2(16S Ct – Gene Ct). Ratios were determined between normalized sample values
to produce fold differences.
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Poly-N-acetylglucosamine (PNAG) slot blot. PNAG slot blots were performed essentially
as described previously by Cramton et al. (2001) with minor modifications. Bacteria
were grown overnight in TSBG or TSBG + 10 µg chloramphenicol/ml + 1mM IPTG. For
cell surface extracts 109 cells were collected by centrifugation, washed once with PBS,
and resuspended in 250 µl of 0.5M ethylenediaminetetraacetic acid (EDTA). To
analyze secreted PNAG, 250 µl of spent media was retained. All samples were
incubated in boiling water for 5 minutes, cooled, and incubated at 65°C for 1 hour with
20 µl proteinase K. Samples were boiled for an additional 5 minutes to inactivate the
protease, diluted in 1X PBS, and immobilized on a nitrocellulose membrane that was
pre-wetted in 10% methanol in 1X-PBS with a vacuum manifold. The membrane was
blocked overnight at 4°C in 5% bovine serum albumin diluted in 1X PBS, then probed
with 1:5,000-diluted rabbit antiserum specific for PNAG (kindly provided Dr. Gerald B.
Pier) (Maira-Litran et al., 2002) in 1X PBS + 1-2% blocking solution + 0.05% Tween-20
(Fisher Scientific, Pittsburg, PA) for 2 hours at room temperature, while rocking. The
membrane was washed three times for 5 minutes with 1X PBST (PBS + 0.05% Tween20), and then probed with 1:10,000- diluted goat anti-rabbit immunoglobulin-horseradish
peroxidase conjugate (Invitrogen, Grand Island, NY) in 1X PBST for 1 hour at room
temperature, while rocking. Bands were visualized with the ECL Plus western blotting
detection system (GE Healthcare). The blot was incubated in the chemiluminescence
developing reagent for 1 minute, covered in plastic wrap, exposed to X-ray film and
developed in an X-O-Mat.
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Isolation of JB12 mucoid revertants. Six-well polystyrene plates (CellTreat, Shirley, MA)
were inoculated with individual colonies of JB12 in LB, grown at 37°C for 3 days,
replacing the media every 24 hours. To collect mucoid revertants the wells were
washed once with sterile 1X PBS, remaining adherent cells were scraped from the
surface of the well and resuspended in PBS. After plating on CRA, colony morphology
was visually assessed to identify mucoid CFUs.

Fitness determination. Cultures were grown overnight in TSBG, and gently sonicated for
30 seconds. Each culture was diluted to a concentration of 103 cells and mixed 1:1 with
MN8m + JB12, with separate tubes for each time point. The cultures were incubated at
37°C, 200 rpm. At each time point the cultures were gently sonicated, serially diluted
and plated in triplicate on CRA plates for CFU counting. Calculation of the difference in
fitness was determined using the function derived from Sander et al. (2002):
)# nmt mt &1 gen ,
Mt = ln +%
( .
+*$ nmt − 1 mt − 1 ' .-

€ non-mucoid and mucoid cells, respectively at a given
where nmt and mt represent the

time t. While nmt-1 and mt-1 denote the quantity of non-mucoid and mucoid cells at the
preceding time point. The quotient of the ratios was standardized with the exponent
1/generation, with the assumption that cell numbers determined at 24 hours represents
approximately 17 generations. The relative bacterial fitness for a given time was
calculated as fitt = 1 + Mt . The fitness value is equal to 1 if there is no difference in
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fitness between the competing strains, less than 1 if the non-mucoid phenotype reduces
fitness, or greater than 1 if the non-mucoid phenotype increases bacterial fitness.

Cell survival in nutrient-limited conditions. Liquid cultures were initially grown shaking
aerobically in TSBG for 24 hours at 37°C, 200 rpm. Bacteria were collected by
centrifugation, and equal numbers of bacteria for each sample were resuspended in
equal volumes of MOPS minimal media with no glucose, or other carbon source. The
cultures were incubated at 37°C while shaking. At each time point the cultures were
serially diluted and plated in triplicate on TSA plates for CFU enumeration. Each strain
was analyzed in technical triplicate and biologic replicates.

Polyacrylamide gel electrophoresis. Protein gels were run using the NuPAGE SDSPAGE Gel system (Invitrogen, Grand Island, NY) according to manufacturer’s
instructions with slight modifications. 100 µl of liquid cell culture was collected by
centrifugation, resuspended in 50 µl sterile water, and mixed with 50 µl NuPAGE 4X LS
Sample Buffer and 10 µl NuPAGE Sample Reducing Buffer (Invitrogen). Samples were
incubated in boiling water for 5 minutes, gently sonicated, and loaded into the wells of
NuPAGE 4-12% Bis-Tris 1.0 mm Gel (Invitrogen). The gel was electrophoresed for
approximately 30 minutes at 200 V in 1X NuPAGE Running Buffer. Approximate protein
size was determined by comparison against Precision Plus Protein Kaleidoscope
standard (BioRad, Hercules, CA). Lanes were visualized by staining with Imperial
Protein Stain (Thermo Scientific, Waltham, MA) for 1 hour, and destaining with water
until bands were clearly visible.
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Western blot to detect 6X-His-tagged proteins. A 0.45 µm PVDF membrane (Invitrogen,
Grand Island, NY) was pre-wetted in 100% methanol, then soaked in 1X NuPAGE
transfer buffer (Invitrogen) containing 10% methanol along with transfer paper and
sponges. Following polyacrylamide gel electrophoresis, the gel was prepared for
electrophoretic transfer by rinsing in deionized water and then placed against the PVDF
membrane; surrounded by the transfer paper and sponges to maintain buffer saturation
and tight contact between the membrane and gel, and immersed in the same 1X
NuPage transfer buffer. The transfer was run at 40V for 1 hour at room temperature.
The membrane was blocked overnight at 4°C in 5% skim milk diluted in 1X PBS, then
probed with 1:1,000-diluted rabbit anti-6X HIS Tag primary antibody (Rockland
Immunochemcials, Gilbertsville, PA) in 1X PBS + 1-2% blocking solution + 0.05%
Tween-20 (Fisher Scientific, Pittsburg, PA) for 2 hours at room temperature, while
rocking. The membrane was washed three times for 5 minutes with 1X PBST (PBS +
0.05% Tween-20), and then probed with 1:10,000- diluted goat anti-rabbit
immunoglobulin-horseradish peroxidase conjugate (Invitrogen, Grand Island, NY) in 1X
PBST for 1 hour at room temperature, while rocking. Bands were visualized with the
ECL Plus western blotting detection system (GE Healthcare). The blot was incubated in
the chemiluminescence developing reagent for 1 minute, covered in plastic wrap,
exposed to X-ray film and developed in an X-O-Mat.

Production of recombinant SarA. The primer set sarAFwd (BamHI site) and sarARev
(XhoI site) were used to PCR amplify sarA from MN8 gDNA with directional restriction
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sites on either end of the PCR product. After gel electrophoresis and purification by gel
extraction, the PCR product was restriction digested with BamHI and XhoI (New
England Biolabs, Ipswich, MA) according to manufacturer’s specification. The isopropyl
β-D-1 thiogalactopyranoside (IPTG) inducible plasmid pET32xT was also digested with
BamHI and XhoI, prior to ligation of the digested sarA insert into the vector. The plasmid
construct was used to transform chemically competent E. coli CH3 blue cells (Bioline,
Tauton, MA) with transformants being selected for on LB agar plates containing
ampicillin. The plasmid construct was isolated using the previously outlined plasmid
mini-prep procedure, and the sequence fidelity of the gene insert confirmed by
nucleotide sequencing. The pET32xT-sarA construct was then used to transform
chemically competent E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene, La Jolla,
CA), with transformants being selected for on LB agar plates containing ampicillin and
chloramphenicol.
To induce expression of recombinant SarA, a streak of many BL21+pET32xTsarA colonies was used to inoculate 50 ml of LB containing ampicillin and
chloramphenicol, which was incubated shaking overnight at 37°C. The entire overnight
culture was then transferred into 1 L of LB containing ampicillin and chloramphenicol,
and incubated shaking at 37°C for 2 hours. A 1 ml aliquot was removed and saved prior
to induction with 1 mM IPTG for 2 hours at 37°C. After protein induction, another 1 ml
aliquot was removed and the entire remaining culture centrifuged to collect the bacterial
cells. The pellet was washed once in sterile PBS, and frozen at -80°C for a minimum of
1 hour. To confirm proper protein expression, the pre- and post-induction samples were
run on a polyacrylamide gel as previously described, stained and visualized.
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Purification of recombinant SarA. The induced BL21+pET32xT-sarA pellet was
resuspended in lysis buffer on ice, and sonicated six times for 30 seconds at power
level 5 while remaining on ice. Lysis buffer was composed of 20 mL B-PER Bacterial
Protein Extraction Reagent (Thermo Scientific, Waltham, MA), 150 mM NaCl, 2 mM BME, and one cOmplete EDTA-free protease inhibitor tablet (Roche Applied Science,
Indianapolis, IN). The cell debris was removed by centrifugation, and the supernatant
filter sterilized using a syringe capped with a pre-filter and a 0.45 µm pore filter. A
purification column was prepared with 4 ml of HisPur Cobalt Resin (Thermo Scientific)
washed once with sterile water and once with sterile 1X PBS. The filtered protein
supernatant was applied to the column first, and was subsequently washed four times
with 1X PBS + 10 mM imidazole and one wash with 1X PBS + 25 mM imidazole.
Recombinant protein was eluted from the column with 1X PBS + 200 mM imidazole,
and loaded into a 10K MWCO Slide-A-lyzer Dialysis Cassette (Thermo Scientific) to be
dialyzed overnight in 3 L of 0.1X PBS stirring at 4°C. The protein was removed from the
dialysis cassette and 200 units of thrombin (MP Biochemicals, Solon, OH) added, and
allowed to incubate rocking overnight at room temperature. The mixture was then
poured over a prepared 3 ml HisPur Cobalt Resin column, retaining the flow thru, which
was concentrated to a final volume of 0.5-1 ml by centrifugation in a Amicon 3K Ultracel
centrifugal filter unit (Millipore, Billerica, MA) and stored at 4°C on ice until use. The
location of the expressed SarA protein was monitored throughout the purification
process running all fractions collected on a polyacrylamide gel as previously described,
stained and visualized.
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Electrophoretic mobility shift assay (EMSA). The biotinylated probes were generated
using PCR with the icaProBTFwd and icaProBTRev-BioTEG (Integrated DNA
Technologies, Coralville, IA) primers from either MN8 or MN8m gDNA. A 6.5% nondenaturing polyacrylamide gel (30% acrylamide/ 0.8% bisacrylamide, 1X TBE, 100 µl of
10% ammonium persulfate, and 10 µl TEMED for 15 ml total volume) was prepared.
Approximately 0.2 µg of either biotinylated probe was added to 40 µl of binding buffer-2
(20 mM HEPES pH 7.9, 1 mM DTT, 0.1 mM EDTA, 50 mM KCl, 5% glycerol, and 200
µg/ml BSA) containing 0.5 µg non-specific competitor DNA poly d(I:C), and incubated
on ice for 10 minutes. Recombinant SarA was added at varying concentrations, allowed
to incubate on ice for 30 minutes, and run in the prepared gel at 150 V for 1 hour in
0.25X TBE running buffer. A nylon membrane (Ambion, Austin, TX) was pre-wetted in
0.25X TBE, and the gel contents electrophoretically transferred in the same buffer for 1
hour at 40 V. DNA was UV cross-linked to the membrane using a Stratagene
Stratalinker (La Jolla, CA) auto-crosslink function. Bands were visualized using the
Thermo Scientific Chemilumiscent Nucleic Acid Detection kit (Waltham, MA) according
to manufacturer’s directions, with one modification: Pierce High Sensitivity StreptavidinHRP (Thermo Scientific, Waltham, MA) was used at 1:10,000 in place of the kit
reagent. After application of the working solution for 3 minutes, the membrane was
covered in plastic wrap, exposed to X-ray film and developed in an X-O-Mat.

In silico prediction of curvature/bendability. The nucleotide sequence surrounding the
S. aureus MN8m 5 bp deletion in the ica promoter region, as well as the same intact
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region from strain MN8 was submitted to the bend.it server; which calculated the
bendability/curvature propensity plots, using the DNase I-based bendability parameters
of Bruckner et al. (1995) and the consensus bendability scale (Gabrielian & Pongor,
1996).

Analysis of intrinsic DNA bending. PCR was used to amplify the selected ica promoter
region with the icaProBend1-Xba and icaProBend2-Sal primers from either MN8 or
MN8m gDNA with directional restriction sites on either end of the PCR product. After gel
electrophoresis and purification by gel extraction, the PCR product was restriction
digested with XbaI and SalI (New England Biolabs, Ipswich, MA) according to
manufacturer’s specification. The plasmid pBEND2 was also digested with XbaI and
SalI, prior to ligation of the digested ica promoter fragment inserts into the vector. The
plasmid construct was used to transform chemically competent E. coli CH3 blue cells
(Bioline, Tauton, MA) with transformants being selected for on LB agar plates containing
ampicillin. The plasmid construct was isolated using the previously outlined plasmid
mini-prep procedure in large quantity, and the sequence fidelity of the gene insert
confirmed by nucleotide sequencing. Individual aliquots of approximately 100 µg of both
the MN8 and MN8m-derived pBEND-icaPro constructs were restriction digested with
BglII, NheI, SpeI, EcoRV, SspI, or BamHI (New England Biolabs). A 15 x 15 cm 10%
polyacrylamide gel was prepared (1X Tris-Cl/SDS pH 8.8, 30% acrylamide/ 0.8%
biasacrylamide, 350 µl of 10% ammonium persulfate, and 35 µl TEMED for 45 ml total
volume). 1X loading buffer (5X stock composed of 25% glycerol and 2.5X TBE) was
added to each of the plasmid digests prior to loading the gel, which was run at 30 V for
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48 hours at 4°C. The gel was soaked in 0.5 µg/ml ethidium bromide for 30 minutes at
room temperature and then visualized under UV light. DNA size was determined by
comparison against the Hyperladder II DNA molecular weight marker (Bioline, Taunton,
MA)
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CHAPTER 3
Investigating the molecular mechanism responsible for icaADBC hypertranscription in Staphylococcus aureus strain MN8m

Introduction
Gene regulation can be modulated by means beyond the ability of the nucleotide
sequence of DNA to encode proteins; the physical and structural characteristics of the
DNA molecule itself may play an important role in influencing gene expression. There is
ample evidence for the importance of DNA flexibility in the action of DNA-binding
proteins altering the physical conformation of bound DNA, either to effect gene
regulation through positive or negative control. Rigid DNA curvature reduces its
bendability, and intrinsic curvature of the DNA results from certain nucleotide
sequences. Tracts of A or T longer than 3 base pairs are considered to be major
determinants of intrinsic curvature, and extended poly-A or poly-T tracts exhibit a
particularly high degree of rigid curvature (Perez-Martin & de Lorenzo, 1997). Therefore,
mutations can impact cellular processes not only because of how the change to the
specific sequence affects transcription/translation/protein function directly, but also in
how they alter the physical DNA architecture of the region they occupy.
SarA is a major staphylococcal global regulator protein that has been implicated
in the control of more than 120 different genes, and is an important positive regulator of

	
  

37	
  

icaADBC transcription (Tormo et al., 2005). SarA is a dimeric protein composed of a
central helical core and two winged helix motifs that each contain a helix-turn-helix
motif, and both of which are capable of binding DNA (Liu et al., 2006). The winged
domain recognizes the minor groove of DNA, while the helix-turn-helix interacts with the
major groove. This binding of DNA compresses it, narrowing the minor groove and
overwinding the helices, causing SarA-bound DNA to more closely resemble D-DNA
that the more common B-DNA conformation (Schumacher et al., 2001). Recent work
has begun to expand our knowledge of SarA beyond the traditional role of a classical
transcription factor. It is unique in that it appears to demonstrate highly promiscuous
binding affinity (DNA, RNA, etc), and is present in much higher amounts at all stages of
growth than classic transcription factors, but is not always functionally active (Fujimoto
et al., 2009). There is currently significant debate over how exactly SarA recognizes
DNA, since binding is promiscuous and evidence of a consensus binding sequence thus
far is weak and limited to AT-rich regions. An alternative theory was put forth by
Fujimoto et al. (Fujimoto et al., 2000) which suggests that SarA is an architectural
protein that instead recognizes specific physical/topological characteristics of DNA for
binding.
We have previously identified a spontaneous 5-bp deletion in the intergenic
region between icaA and icaR that causes constitutive activation of the icaADBC
operon, leading to an increase in PNAG production of up to 10,000-fold. The strain
carrying this mutation, MN8m, has a distinct mucoid phenotype. However, the exact
mechanism by which his small change induces such a profound increase in PNAG
production remains unknown. We hypothesize that the deletion in the icaADBC
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promoter region causes a significant change in the regional physical characteristics of
the DNA, possibly allowing it to be more flexible in its interactions, leading to optimal
transcriptional activation of icaADBC. We chose to include the interaction of SarA with
our promoter region as a tool to better elucidate the mechanism responsible for
increased PNAG production because it is a positive regulator of icaADBC that may
influence transcriptional activity by altering the DNA topology/architecture. It is thought
that it binds to and bends DNA in the 5ʼ region of the gene in such a way as to alter the
spacing between the -10 and -35 regions (Fujimoto et al., 2009). We theorized that
SarA binds to the icaADBC promoter region and maximizes the spacing, and that the 5bp deletion responsible for the mucoid phenotype maximizes this spacing even in the
absence of SarA.

Results
Effect of MN8m promoter deletion on intrinsic DNA curvature/flexibility
We have hypothesized that a potential molecular mechanism underlying the
constitutive icaADBC transcription of strain MN8m may be related to the 5-bp deletion in
its promoter region causing a significant change in the physical characteristic in that
region of DNA. Preliminary in silico analysis was performed using the bend.it server
(Vlahovicek et al., 2003) to predict the effect of the deletion on the intrinsic DNA
curvature and bendability of the 150 base pairs surrounding it (Fig. 4) since regions of
bent DNA tend to span only a few dozen nucleotides. We found that alteration in the
predicted characteristics was only observed in the 20 base pairs immediately
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surrounding the deletion mutation site, a very small difference. We observed that the
loss of those 5 base pairs reduced the predicted curvature of that region of DNA from
approximately 3.0 °/helical turn to 0.5 °/helical turn, and slightly increased predicted
bendability from 3.25 to 4 a.u. However, in general, values below 5.0 °/helical turn
indicate a region of straight DNA with little to no curvature.
This observation was supported by our analysis directly comparing the intrinsic
curvature of the altered DNA sequence in vitro using the plasmid vector pBEND2. The
region of DNA from the ica promoter of both strains MN8 and MN8m inserted into the
pBEND2 vector is shown in Figure 5.A. Use of the pBEND vector to determine
curvature relies on the observation that the mobility of a DNA fragment in a
polyacrylamide gel decreases as the center of any bent regions approaches the center
of the fragment (Kim et al., 1989). Therefore restriction digest of pBEND2 containing the
ica promoter region yields fragments of identical size with location of the inserted DNA
fragment being varied (Fig. 5.B). Electrophoresis of the digested inserts, which differ
only in the position of the predicted bending center, was analyzed to determine K values
from the ratio of observed size to actual size of the two inserts with the greatest
observed difference (Fig. 6, Table 3). Supporting the assumption that predicted
curvature values of less than 5.0 °/helical turn indicating a region of straight DNA, K
values of approximately 1.1 indicate no significant point of bending. Additionally, these
results determine that the 5-bp deletion responsible for the constitutive transcription of
icaADBC in MN8m does not have a detectable effect on this aspect of DNA topology in
its vicinity.
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Figure 4. In silico prediction of bendability/curvature effects of the MN8m
promoter deletion. Bendability/curvature propensity plots generated by the bend.it
server for the nucleotide sequence 150 bp around the deletion site; the deletion site is
outlined.
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Figure 5: Schematic representation of the DNA sequence region to be inserted
into the pBEND2 vector. A.) The region of DNA containing the MN8m deletion site to
be inserted into the pBEND2 vector is highlighted in pink. Putative SarA binding sites
are indicated by the red lines, and other promoter function sites are labeled. B.) The
multiple cloning site of pBEND2 with reciprocal restriction digest sites. The fragments
generated by BglII, NheI, SpeI, EcoRV, SspI, and BamHI restriction digest are shown
with the position of the insert indicated.
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Figure 6: Analysis of intrinsic curvature of the promoter regions of S. aureus
strains MN8 and MN8m. Restriction digests of pBEND2 containing either the MN8 or
MN8m ica promoter segment electrophoresed on a polyacrylamide gel at 4°C, and
visualized with ethidium bromide. Lane 1 contains BglII digested vector construct, lane 2
NheI, lane 3 SpeI, lane 4 EcoRV, lane 5 SspI, and lane 6 BamHI. The digested
fragments selected for curvature analysis are indicated in the boxed areas.
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Table 3. Determination of MN8m ica promoter deletion on intrinsic DNA curvature
Strain Origin of Insert

Actual Size (bp)

Observed Size (bp)

K Value

MN8

203

215 - 230

1.059 - 1.133

MN8m

198

215 - 225

1.086 - 1.136
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Expression and purification of recombinant SarA
The S. aureus global regulator SarA is an important positive regulator of ica that
has been shown to bind in and around its promoter region (Tormo et al., 2005). We
speculated that the 5-bp promoter deletion in the strain MN8m might influence binding
of SarA leading to the increased icaADBC expression. To investigate how SarA
interacts with the intact versus deletion-modified promoter region, we first needed to
heterologously express and purify recombinant SarA. The sarA gene was cloned into
the IPTG-inducible pET32xT vector (generously supplied by Dr. David Williams, VCU,
Richmond, VA), which attaches a C-terminal Thio-HIS tag to the protein. The
recombinant protein was expressed in E. coli BL21-CodonPlus(DE3)-RIL cells.
Expression of the expected Thio-HIS-tagged SarA product was confirmed by SDSPAGE with the presence of a protein of approximately 34 kDa upon induction with 1 mM
IPTG (Fig. 7.A), and by Western blot probed with 6X-HIS antisera showing a product of
the same size after induction (Fig. 7.B). The expressed recombinant protein was
isolated by column purification using cobalt resin (Fig. 8.A), and the Thio-HIS tag was
removed by thrombin cleavage and separated from the 14.7 kDa SarA through
repetition of cobalt column purification (Fig. 8.B).

SarA binding to the ica promoter region
To investigate our hypothesis that the MN8m deletion alters SarA binding
to the ica promoter region, modulating PNAG expression, we utilized our purified
recombinant SarA and the 100-bp region around the MN8m deletion (Fig. 9.A) for DNA
binding gel shift assays. The DNA fragments from both MN8 and MN8m were
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biotinylated and incubated with various amounts of the SarA protein, ranging from 0.010.9 µg, in the presence of the non-specific oligo competitor poly d(I:C). The EMSAs for
both promoter fragments showed that the 5-bp deletion in strain MN8m had no
discernable effect on SarA binding to that region (Fig. 9.B). The retarded protein-DNA
complexes were visible for both strains beginning at 0.1 µg of SarA. A complete shift
was observed between 0.05 µg and 0.1 µg of SarA (the lower band for MN8 at 0.2 µg
SarA was not observed in independent replicates, and variance in band intensity is
experimental artifact). These results indicated that partial binding could be observed at
SarA amounts between these two concentrations to further characterize the DNAbinding affinity of SarA to this sequence fragment. Additionally, shifted bands of different
sizes were observed at SarA amounts greater than 0.3 µg, supporting the existence of
several SarA-binding sites within this region of the icaADBC promoter.

Effect of SarA on the mucoid phenotype of MN8m
While we observed that the 5-bp deletion in the icaADBC promoter responsible
for the mucoid phenotype of S. aureus strain MN8m does not affect SarA binding affinity
for the region, we wanted to further elucidate the potential role of this positive regulator
on the hyper-activation of the operon. It is thought that SarA binds to and bends
promoter DNA in such a way as to optimize spacing, generally between the -10 and -35
regions, and promote transcription (Fujimoto et al., 2009). We theorized that SarA binds
to the icaADBC promoter region and maximizes the spacing (although it does not lie
between the -10 and -35 regions) and that the 5-bp deletion responsible for the mucoid
phenotype maximizes this spacing even in the absence of SarA. To investigate this
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Figure 7: Heterologous expression of S. aureus 6X-HIS-tagged recombinant SarA
in E. coli. (A) Imperial-stained SDS-PAGE of cell lysates of uninduced E. coli BL21CodonPlus(DE3)-RIL containing pET32xT-sarA, and the same strain induced for 2
hours with 1 mM IPTG. Approximate molecular weights indicated. (B) Western blot of
the same cell lysates probed with anti-6X-HIS Tag antiserum. Approximate molecular
weights indicated.
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Figure 8: Purification of S. aureus recombinant SarA. (A) Purification of 6X-HIS
tagged recombinant SarA from culture lysate of IPTG-induced E. coli BL21CodonPlus(DE3)-RIL containing pET32xT-sarA using a cobalt resin column. An
Imperial-stained SDS-PAGE gel, in which Lane 1 contains initial flow through after
application of the culture lysate, Lane 2 represents the beginning of four column washes
with 1X PBS + 10mM imidazole, Lane 3 contains a single wash with 1X PBS + 25mM
imidazole, Lane 4 elution of the bound protein with 1X PBS + 200mM imidazole, and
Lane 5 contains the remaining cobalt resin. Approximate molecular weights are
indicated. (B) An Imperial-stained SDS-PAGE gel of the previous protein elution after
treatment with thrombin to cleave the Thio-HIS tag from the recombinant SarA, and
passage over a cobalt column to remove the tag. Approximate molecular weights are
indicated.
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Figure 9: Comparison of SarA binding to the MN8 and MN8m ica operon promoter
regions. (A) Schematic representation of the nucleotide sequence (highlighted in pink)
from both MN8 and MN8m that was biotinylated for use as specific binding probes.
Putative SarA binding sites are indicated by red lines. (B) Electrophoretic mobility shift
assays with biotinylated specific probes and non-specific competitor DNA, used to detect
binding of SarA to the selected region of S. aureus strains MN8 and MN8m. Membranes
were x-ray visualized after electrophoresis and electrophoretic transfer with streptavidinHRP.
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hypothesis that SarA is non-essential for icaADBC expression in MN8m, we first
constructed a group of isogenic S. aureus mutant strains: RN4220∆ica,
RN4220∆ica+pBT9-M1 (in which the deletion has been complemented in trans by the
entire icaRADBC locus under the control of the MN8m-type promoter on the vector
pBT9), and RN4220∆ica∆sarA+pBT9-M1. When these three strains were plated on
Congo red agar (CRA), we observed only non-mucoid colonies as expected for the
PNAG-negative strain RN4220∆ica, which are slick, circular, and occasionally
surrounded by a transparent red perimeter (Fig. 10). However, RN4220∆ica+pBT9-M1
and its isogenic sarA mutant strain RN4220∆ica∆sarA+pBT9-M1 both formed mucoid
colonies similar to those observed in strain MN8m, which appear dry with irregular
edges.
The observation that there was no discernible difference in the mucoid colony
morphology between the SarA-positive and SarA-negative strains, suggested that SarA
may not be required for PNAG synthesis in strains containing the 5 bp deletion in the
icaADBC promoter. To test this, we performed slot-blot analysis using PNAG-specific
rabbit polyclonal antiserum. As depicted in Figure 11, no PNAG was detected in the icanegative strain, while it was detected on the surface of both RN4220∆ica+pBT9-M1 and
RN4220∆ica∆sarA+pBT9-M1, supporting the previous observation of a mucoid
phenotype. Not only was SarA not required for PNAG synthesis, but there actually
appeared to be more PNAG present in the SarA-negative cultures, indicating a potential
negative effect of SarA on expression of the mucoid icaADBC operon.
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Role of SarA in MN8m icaADBC hyper-transcription
The icaADBC genes are co-transcribed, so to determine the influence of SarA on
levels of the full-length transcript produced by the mucoid promoter, we quantified levels
of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in Figure 12, icaADBC
transcript levels were more than 30-fold greater in RN4220∆ica∆sarA+pBT9-M1 than in
the isogenic SarA-positive strain RN4220∆ica+pBT9-M1. These results support the
previous observation that SarA is not essential for icaADBC expression from the mucoid
promoter. Furthermore, it appears that in the presence of the MN8m promoter deletion,
SarA has a negative impact on transcriptional activation.

Discussion

Virtually nothing is known about the molecular mechanism underlying the
constitutive production of PNAG in S. aureus strain MN8m, aside from the fact that it is
caused by a 5 bp deletion in the icaADBC promoter region. We have hypothesized that
the increased transcriptional activation of icaADBC may be due to the mutation altering
the topology or physical traits of the DNA structure in its vicinity. We have predicted and
confirmed that the DNA in the icaADBC promoter region is predominantly linear, with no
detectable intrinsic curvature, and that this does not change when the MN8m deletion is
present. However, while we have shown that there is no intrinsic bend in the icaADBC
promoter, this does not rule out that the 5 bp deletion in MN8m could increase DNAbinding protein-induced curvature to better stimulate transcription or relieve repression.
Additionally, one alternative theory that should be pursued further is that the 5 bp
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Figure 10: Effect of sarA on mucoid colony morphology. Bacterial colonies from
strains RN4220∆ica, RN4220∆ica+pBT9-M1, and RN4220∆ica∆sarA+pBT9-M1 were
grown on Congo red agar (CRA). Strains containing pBT9 were grown on CRA
containing chloramphenicol.
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Figure 11: Effect of sarA on PNAG production. PNAG slot blot analysis of S. aureus
strains producing different amounts of plasmid encoded PNAG; probed with PNAGspecific polyclonal antiserum. Samples for both strains containing the mucoid plasmid
pBT9-M1 were diluted 1:10 further than indicated prior to immobilization on membrane.
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Figure 12: Effect of sarA on ica mRNA transcript levels. Real-time RT-PCR analysis
of icaC mRNA transcript was performed. Bars represent the mean fold difference in
transcript amount relative to strain RN4220∆ica+pBT9-M1 with biological replicates n =
3, and error bars indicate the standard deviations. Statistical comparison (unpaired t
test) of RN4220∆ica+pBT9-M1 versus RN4220∆ica∆sarA+pBT9-M1 gave a P value of
<0.0015.
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deletion produces its effect by inducing a 180 degree turn in the helical face of
downstream DNA elements, potentially optimizing transcription activating interactions
(between RNA polymerase and DNA, or another effect0r protein).
SarA is a positive regulator of icaADBC transcription that is known to bind to the
ica promoter region (Tormo et al., 2005). While the exact binding site(s) is not known,
we observed that the MN8m 5 bp deletion disrupts a putative SarA binding site as
suggested by Tormo et al. (2005), leading us to hypothesize that binding of SarA might
be altered in strain MN8m, increasing icaADBC transcription. However, we
demonstrated through electrophoretic mobility shift assays that there is no detectable
difference in the binding affinity of SarA to either the MN8 or MN8m promoter regions.
We were able to conclude that there are likely to be multiple SarA binding sites within
this region of DNA; and although it is not clear exactly where on the DNA SarA is
binding, we intend to use our existing system to identify the preferred SarA binding sites
to determine if sequence consensus is important. It is also worthy to note that we have
devised a reliable in vitro method for heterologous expression and efficient purification
of large quantities of recombinant SarA that is functionally active.
The most interesting observations of our work addressed the involvement of
SarA in the constitutive transcriptional activation of icaADBC in MN8m. We initially
theorized that while SarA is still capable of binding the promoter in such a way as to
alter DNA element spacing (although it does not lie between the -10 and -35 regions),
the 5-bp deletion responsible for the mucoid phenotype maximizes this spacing even in
the absence of SarA, rendering SarA non-essential for ica expression in MN8m. This
hypothesis has thus far been supported by our observations that the mucoid colony
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morphology and hyper-PNAG production is maintained in a SarA-negative mucoid strain
background. However, we concurrently observed that not only was SarA not necessary
but that its absence increased icaADBC transcript levels and detectable PNAG
production. These results expanded our hypothesis to include the likelihood that not
only is SarA no longer responsible for ica expression, its presence appears to interfere
with transcriptional activation. This conclusion is unique in that SarA is a wellcharacterized positive regulator of icaADBC, and here we have demonstrated that in the
MN8m strain background it acts as a negative regulator. This is possibly due to the
physical presence of SarA bound to the promoter sterically hindering even greater
transcription initiation by another effector, possibly RNA polymerase alone (autoactivation of transcription) or other unknown transcription factors.
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CHAPTER 4
Characterizing Novel Phase Variation of Poly-N-Acetylglucosamine in
Staphylococcus aureus

Introduction
Phase variation functions as a reversible on/off switch for the expression of a
particular gene. The result is commonly an alteration in the expression of some cell
surface-expressed antigen. Slipped-strand mispairing is one mechanism that can lead
to the production of a phase variant. Slipped-strand mispairing occurs during DNA
replication when there is mispairing between mother and daughter DNA strands in
regions of DNA that contain simple 1-10 nucleotide repeats (Levinson & Gutman, 1987).
This results in the addition or subtraction of one or more repeats that can bring about a
change in transcriptional efficiency or shift the reading frame to alter or halt translation.
We found previously that a 5-nucleotide deletion mutation within the icaADBC
promoter of strain MN8m was sufficient to induce constitutive transcription of the
icaADBC genes and high-level PNAG production, resulting in a mucoid phenotype and
strong biofilm production (Jefferson et al., 2003). In the present study, we noted that
growth of the mucoid strains in liquid culture resulted in the rapid accumulation of nonmucoid variants suggesting that either mutation to the non-mucoid phenotype occurred
at high frequency or that the non-mucoid variants had a selective growth advantage. We
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investigated this phenomenon and found that the most frequent mutation leading to the
phenotypic variation was a slipped-strand mispairing in icaC.

Results
Non-mucoid variants accumulate in cultures of a mucoid S. aureus strain
S. aureus strain MN8m is a spontaneous PNAG-overproducing mutant of strain
MN8 (Jefferson et al., 2003). It is highly aggregative in liquid culture whereas nonmucoid strains are dispersed, making the culture turbid (Fig. 13). We found that MN8m
cultures frequently exhibited an appearance that was somewhere between that of a
turbid, non-mucoid strain and an auto-aggregative mucoid strain (Fig. 13). When these
cultures were plated on Congo red agar (CRA), both mucoid colonies, which appear dry
with irregular edges, and non-mucoid colonies, which are slick, circular, and
occasionally surrounded by a transparent red perimeter, were observed (Fig. 14).
Several of the non-mucoid MN8m variants were isolated and assigned names based on
JB10-22; one of the strains selected for further characterization was JB12. We
compared the biofilm-forming ability of the non-mucoid variant JB12 to MN8 (the strain
from which MN8m derived), which produces a low level of PNAG (considered wild-type),
and to the PNAG-negative strain MN8Δica (Fig. 15). The JB12 strain displayed a
significant decrease in biofilm formation, most closely resembling the PNAG-negative
strain MN8Δica.

Analysis of non-mucoid variant JB12 to determine PNAG expression
The finding that JB12 biofilms resembled those of the PNAG-negative strain
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Figure 13: Variation in MN8m planktonic growth phenotype. Liquid cultures in
TSBG of (A) highly aggregative mucoid MN8m, (B) non-mucoid MN8, and (C) MN8m
with mixed appearance.
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Figure 14. Colony morphology of non-mucoid variants isolated from mucoid
strain MN8m. Bacterial colonies of MN8, MN8∆ica, MN8m, and the JB12 and JB17
variants on Congo red agar (CRA) plates.
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Figure 15. Biofilm formation by the non-mucoid variant, JB12. Biofilm formation
was assessed by visualization of biofilms formed on microtiter plate wells by safranin
staining and quantitative data was obtained by resuspending the safranin in acetic acid.
Bars represent the mean OD562 nm of n = 6, and error bars indicate the standard
deviations. Statistical comparison (unpaired t test) of MN8m versus JB17 gave a P
value of <0.001.
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MN8Δica suggested that PNAG production was severely abrogated or absent in JB12.
To test this, we performed slot-blot analysis using PNAG-specific rabbit polyclonal
antiserum. As depicted in Figure 16, no PNAG was detected on the cell surface or in
the spent media of JB12 cultures. Therefore, the molecular mechanism leading to the
non-mucoid phenotype appeared to be mediating the variation through the loss of
detectable levels of PNAG.

icaADBC transcript level of JB12
A 5 bp deletion in the icaADBC promoter region of MN8m is responsible for
constitutive icaADBC transcription and the constitutive hyper-production of PNAG that
characterizes strain MN8m (Jefferson et al., 2003). We sequenced this region of DNA in
strain JB12 and found that the ica promoter region was identical to MN8m. The
icaADBC genes are co-transcribed, so to determine levels of the full-length transcript,
we quantified levels of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in
Figure 17, icaADBC transcript levels were more than 300-fold greater in MN8m than in
the non-mucoid parent strain MN8 and the level remained elevated in the non-mucoid
variant. These results indicate that the loss of PNAG production was not due to a
decrease in the level of icaADBC transcript, but rather that it was mediated by a posttranscriptional mechanism affecting PNAG synthesis.

Identification of a frequent mutation within a repeat region of icaC
Since the 5 bp promoter deletion remained and there was no detectable
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Figure 16. PNAG production by the non-mucoid variant, JB12. PNAG slot blot
analysis of S. aureus strains producing different amounts of PNAG; probed with PNAGspecific polyclonal antiserum. Samples for both MN8m cell surface and spent media
were diluted 1:10 prior to immobilization on membrane.
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Figure 17. Levels of ica transcript in the non-mucoid variant, JB12. Real-time RTPCR analysis of icaC mRNA transcript was performed. Bars represent the mean fold
difference in transcript amount relative to strain MN8 with n = 3, and error bars indicate
the standard deviations. Statistical comparison (unpaired t test) of MN8m and JB12
versus MN8 gave a P value of <0.001.
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difference in icaADBC transcript levels, DNA sequencing of the entire operon was
performed. A 4 bp insertion was identified in the coding region of icaC (Fig. 18),
extending a small region of “ttta” repeats from three units to four. The insertion led to a
shift in the translational reading frame and truncation of the protein, reducing IcaC from
350 amino acids to 303.
To confirm that the nucleotide insertion was responsible for loss of the mucoid
phenotype, we complemented the icaC gene in trans. Expression of the intact icaC
gene in strain JB12 from the IPTG-inducible plasmid pCL15, lead to restoration of the
mucoid colony morphology on CRA plates (Fig. 19), PNAG synthesis (Fig. 21), and
biofilm formation (Fig. 20). Introduction of the empty vector into the variant had no
effect.
Additionally, we found that variations in the number of 4 bp repeats in this region
appears to be a frequent mutation among non-mucoid variants isolated from pure
MN8m cultures. The icaADBC loci of twelve isolates with the PNAG-negative phenotype
from different cultures were sequenced. Seven of these were shown to have either
insertion or deletion of a repeat unit in the same region. Furthermore, examination of
published S. aureus sequences revealed three clinical MRSA strains (TW20, JKD6008,
and T0141) and two partially sequenced clinical isolates (SA21178 and SA21342)
exhibiting 2-3 additional repeat units (Fig. 22) demonstrating that the phase variants
occur in vivo.
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Figure 18. Schematic representation of the ica locus showing the position of the 4
bp insertion in the region of repeats identified in icaC of the non-mucoid variant
JB12.
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Figure 19. Effect of complementation of JB12 with icaC in trans on colony
morphology. Bacterial colonies of MN8 and JB12 and JB12 on Congo red agar (CRA),
and JB12+empty vector or icaC on CRA+Cm+ 1mM IPTG.
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Figure 20. Effect of complementation of JB12 with icaC in trans on biofilm
formation. Biofilms formed in TSBG or TSBG+Cm+1mM IPTG on microtiter plate wells
were stained with safranin and the safranin was quantified by resuspending in acetic
acid and measuring OD562 nm. Bars represent the mean of 6 replicates, and error bars
indicate the standard deviations. Statistical comparison (unpaired t test) of JB12+pCL15
(empty vector) versus JB12+pCL15-icaC gave a P value of <0.001.
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Figure 21. Effect of complementation of JB12 with icaC in trans on PNAG
production. PNAG slot blot of cell surface fractions cultured in TSBG or
TSBG+Cm+1mM IPTG probed with polyclonal anti-PNAG antiserum (MN8m and
JB12+pCL15-icaC samples were diluted 1:10 prior to immobilization on membrane
whereas JB12 and JB12+pCL15 were not diluted).

	
  

86	
  

	
  

87	
  

Figure 22. Nucleotide sequence alignment of the region of repeats identified in
icaC. Comparison of mucoid MN8m and non-mucoid isolate JB12 with five published
sequences of S. aureus clinical isolates.
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Isolation of JB12 mucoid variants
Phase variation is, by definition, an on/off switch. Therefore, if the mutation that
we isolated was a product of phase variation, then we would expect the variant JB12 to
revert to the mucoid phenotype. To determine whether or not the phenotype was
reversible we plated cultures of JB12 onto CRA. We did not observe any mucoid
colonies initially when we plated JB12, so we grew cultures on tissue culture-treated
polystyrene for 36 hr to encourage adherence of PNAG-producing bacteria and plated
the adherent fraction onto CRA. This selection method resulted in the isolation of
mucoid colonies. To confirm that these JB12 mucoid variants supported our theory of
phase variation and did not have a compensatory mutation elsewhere it the genome of
ica locus, we sequenced 6 isolates from separate cultures. All 6 variants sequenced
had lost the 4 bp repeat unit that was gained in JB12 meaning that they had reverted to
MN8m genotype. These results support a mechanism of phase variation through slipstrand mispairing. However, the requirement for a selection process to isolate mucoid
revertants suggested that the number of revertants was very low. We hypothesized that
this was due to a fitness cost imparted by high-level PNAG production.
Fitness cost of PNAG over-production
To determine if there was a fitness cost associated with constitutive PNAG
synthesis, we inoculated competitive co-cultures of MN8m and JB12 equally and
examined shifts in the population over time by assessing colony morphology on CRA.
We observed that there does indeed appear to be significant growth advantage in the
PNAG-negative variant JB12. Growth curves revealed slower growth in MN8m relative
to JB12 (Fig. 23), while competitive co-culture of equal amounts MN8m and JB12
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showed that JB12 almost completely took-over the culture in a relatively short amount of
time (Fig. 24). Direct calculation of the fitness cost of PNAG over-production versus
PNAG loss resulted in fitt (relative bacterial fitness) values of +1.401 at 6 hours, and
+1.386 at 12 hours, with a value greater than 1 indicating a significant fitness advantage
of the JB12 PNAG-negative phenotype over the mucoid MN8m.

Effect of partial function of PNAG synthesis pathway on cell survival
Since only the function of IcaC appears to be altered in this phase variable
control of PNAG production, we hypothesized that the remaining components of the
synthesis pathway (IcaA, IcaD, and IcaB) that are still present in functional forms may
have alternative roles within the cell. We compared the growth rates in liquid culture of
MN8∆ica, which lacks all four genes and produces no PNAG synthesis proteins, and
JB12, which has intact IcaA, IcaD, and IcaB, but found no difference. However, under
starvation conditions, when the strains were switched to incubation in minimal media
containing no carbon source, there was a significant difference in bacterial survival (Fig.
25). Production of intact, and presumably functional IcaA, IcaD, and IcaB significantly
increased survival of JB12 under these growth-limiting conditions.

Discussion
This study was based upon our observation that cultures of the mucoid strain
MN8m frequently appeared to be a mixture of mucoid and non-mucoid bacteria. We
hypothesized that either there was a molecular mechanism for phase variation resulting
in a mutation frequency higher than what would be expected for random mutagenesis or
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Figure 23. Growth comparison of MN8m and JB12. Strains were grown in TSBG.
Points represent the mean percent value of OD600 nm at each time point with n = 3, and
error bars indicate the standard deviations.
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24

Figure 24. Fitness of MN8m versus JB12. The competitive fitness of MN8m in coculture with PNAG-negative, non-mucoid JB12 was determined by combining the two
strains and enumerating each strain over time. Bars represent the value of each
phenotype as a percent of total population, determined by enumerating colonies on
CRA. Values represent the mean of triplicate samples.
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Figure 25. Influence of partial function in PNAG synthesis pathway on survival in
minimal media. MN8m and JB12 were initially grown overnight in TSBG. The cells
were collected and resuspended in minimal media lacking a carbon source to mimic
starvation conditions. Points represent the mean percent value of cells enumerated at
each time point relative to the starting populations with n = 3, and error bars indicate the
standard deviations. Statistical comparison (unpaired t test) of MN8Δica and JB12 at 10
hours and 24 hours gave a P value of <0.001.
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that overproduction of PNAG was detrimental to growth and was associated with a
strong selection bias for mutants. We attempted to determine the mutation frequency;
however, results from different biologic replicates varied by over four orders of
magnitude. We found that there was a strong competitive advantage for the non-mucoid
variants. The growth advantage is likely responsible for the wide variation in apparent
mutation frequency. Depending on the time-point during culture at which a mutation
leading to the non-mucoid phenotype occurred, the variants would have more or less
time to increase in numbers relative to the parent strain due to the growth advantage.
Therefore, the final number of variants present at the end of the culture period would
depend upon the timing of the first mutation event and would be stochastic.
The growth advantage of the non-mucoid variants also explains our difficulty in
isolating mucoid revertants from non-mucoid cultures. We had to grow cultures on
tissue culture-treated polystyrene for three days and select for adherent bacteria in
order to detect mucoid revertants on CRA. Due to the fitness cost associated with
PNAG hyper-production, numbers of mucoid revertants would remain very low relative
to the non-mucoid parent population.
Despite our finding that the PNAG-negative variants enjoyed a fitness advantage,
we hypothesize that it is unlikely for PNAG-negative variants to have a fitness
advantage in vivo. Firstly, we were working with a mucoid variant that arose in vitro and
produces approximately 1,000-fold more PNAG than most clinical isolates. Constitutive
hyper-production of this large polysaccharide almost certainly bears a high metabolic
cost, whereas normal, low-level PNAG production would not. Secondly, in vivo, PNAG
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plays an important role in immune evasion and PNAG-negative variants would likely be
more susceptible to neutrophil-mediated killing. It appears that antibody-mediated
immunity against PNAG is somewhat complex and that only antibodies against
deacetylated PNAG effectively mediate opsonophagocytosis (Maira-Litran et al., 2005).
However, in the event that the host mounts an effective immune response, the capacity
to switch PNAG production off could benefit the bacteria in vivo. It could also benefit the
bacteria in conditions that favor the planktonic mode of growth.
The 5 bp deletion in the MN8m ica promoter leads to constitutive icaADBC
transcription and the accumulation of at least 300-fold more transcript than the clinical
isolate parent strain MN8. Such high-level transcript production and protein synthesis
would seem to be metabolically costly even in the absence of PNAG production. We
therefore found it somewhat surprising that the most common mutation (7 out of 12
variants) occurred within the last gene in the operon (icaC) and that transcript and Ica
proteins were still being produced at MN8m levels. Furthermore, the insertion sequence
IS256 has been shown to turn PNAG synthesis off through insertional inactivation of
icaC (Kiem et al., 2004) suggesting again that mutation of IcaC is the preferred “off
switch” for PNAG production. We tested our hypothesis that there might be some
advantage to continuing synthesis of IcaA, IcaD, and IcaB even though PNAG is not
produced in the absence of IcaC. Our results indicate that under nutrient-limiting
conditions, possession of functional icaADB genes was advantageous for survival. It is
possible that in the absence of functional IcaC, the remaining proteins are still capable
of producing PNAG precursor oligomers within the cell. Therefore, perhaps these
N-acetylglucosamine oligomers can function as a reserve store of UDP-N-acetyl-
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glucosamine under nutrient-limiting conditions and can be degraded to provide
N-acetylglucosamine for other cellular process such as cell wall synthesis. Further work
is needed to more clearly elucidate the roles of the IcaA, IcaD, and IcaB proteins
alternative to their function in PNAG synthesis.
We found that 7 out of 12 of the non-mucoid variants isolated in this study
exhibited an insertion or deletion of 4 bp within a region of simple “ttta” repeats. In
JB12, a “ttta” repeat insertion extends the repeats in this region from three units to four.
This is likely to be the result of slipped-strand mispairing during DNA replication. The
mutation shifts the reading frame, leading to a premature stop codon and truncates the
protein at 303 amino acids, 47 amino acids shorter than the full-length protein.
Structural prediction indicates that the mutation disrupts a transmembrane domain of
IcaC, suggesting that if the truncated protein is present in the bacteria, its location may
be altered. We have preliminary evidence that supports the idea that this phase
variation does have some in vivo relevance, since five clinical isolates have thus far
been identified as possessing variations in the number of “ttta” repeats in this region.
However, in vitro examination of the phenotypic effect of these variable numbers of
repeats needs to be performed.
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CHAPTER 5
Evidence of polarity/translational coupling between icaB and icaC of
Staphylococcus aureus

Introduction
A polar mutation affects the expression of distal genes, and is a frequent
occurrence in prokaryotes. Commonly, a nonsense, frameshift, or insertion mutation
near the promoter proximal region of an upstream gene in a co-transcribed operon
significantly reduces the transcription or translation of downstream genes. One type of
bacterial polarity affecting translation of an operon is called translational coupling.
Translational coupling occurs when complete translation of a gene is necessary for
efficient translation of a downstream gene, and was first identified in the E. coli
tryptophan operon (Aksoy et al., 1984). Coupled genes are commonly found to have
overlapping translational start/stop sites, and the genes products are usually present in
equimolar complexes. Translational coupling is therefore proposed as a molecular
mechanism for maintaining stoichiometric balance between proteins in a synthetic
pathway (Aksoy et al., 1984, Oppenheim & Yanofsky, 1980). There are currently three
supported models of translational coupling. The first type occurs when base-pair
structure within the mRNA masks the initiation site of the downstream gene, and a
translating ribosome from the upstream gene is required to disrupt the secondary
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structure when in proximity, exposing the start site and enabling translation exclusively
by free ribosomes (Berkhout & van Duin, 1985). The second model relies on the same
presence of secondary structure occluding the translational start site of the downstream
gene, but the presence of the upstream translating ribosomes enables translation by
either free ribosomes or continuation of the bound ribosomes (Berkhout et al., 1987,
Das & Yanofsky, 1989). The third model of translational coupling occurs when there is
poor binding of free ribosomes to the Shine-Delgarno sequence, or ribosomal binding
site, of the downstream gene and only bound ribosomes from the upstream gene can
efficiently reinitiate translation upon pausing at the overlap region (Govantes et al.,
1998, Ivey-Hoyle & Steege, 1992).
In the present study we continued our work characterizing the different molecular
mechanisms responsible for the frequent non-mucoid variants that were previously
observed to accumulate in mucoid Staphylococcus aureus strain MN8m cultures. While
the majority of the mutations identified thus far were located in the icaC gene and
characterized by complete loss of PNAG production, another non-mucoid variant was
found to have a nonsense mutation in icaB producing the same phenotype. Given that
previous efforts to delete the icaB gene in S. aureus did not result in a similar
phenotype, we reasoned that the method of deletion by allelic exchange may have
masked an underlying, previously unknown relationship between icaB and the
downstream gene icaC. We therefore hypothesized that a nonsense mutation early in
icaB would have a polar effect on expression of icaC, most likely through translational
coupling of the genes since the stop site of icaB overlaps with the start site of icaC. Our
investigation into this phenomenon thus far has supported polarity between the genes,
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and begun to elucidate the potential for translational coupling although the exact nature
has yet to be fully defined.

Results
Isolation of biofilm-deficient, MN8m non-mucoid variant JB17
As previously outline in Chapter 5, non-mucoid variants have been found to
accumulate in pure cultures of the mucoid S. aureus strain MN8m. When these cultures
were plated on Congo red agar (CRA), both mucoid colonies, which appear dry with
irregular edges, and non-mucoid colonies, which are slick, circular, and occasionally
surrounded by a transparent red perimeter, were observed (Fig. 14). Of the non-mucoid
MN8m variants isolated, one named JB17 was also selected for further characterization.
We compared the biofilm-forming ability of this non-mucoid variant to MN8 (the strain
from which MN8m derived), which produces a low level of PNAG (considered wild-type),
and to the PNAG-negative strain MN8Δica (Fig. 26). The JB17 strain displayed a
significant decrease in biofilm formation, most closely resembling the PNAG-negative
strain MN8Δica.

Analysis of non-mucoid variant JB17 to determine PNAG expression
The finding that JB17 biofilms resembled those of the PNAG-negative strain
MN8Δica suggested that PNAG production was severely abrogated or absent in JB17.
To test this, we performed slot-blot analysis using PNAG-specific rabbit polyclonal
antiserum. As depicted in Figure 27, no PNAG was detected on the cell surface or in
the spent media of JB17 cultures. Therefore, the molecular mechanism leading to the
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Figure 26. Biofilm formation by the non-mucoid variant, JB17. Biofilm formation
was assessed by visualization of biofilms formed on microtiter plate wells by safranin
staining and quantitative data was obtained by resuspending the safranin in acetic acid.
Bars represent the mean OD562 nm of n = 6, and error bars indicate the standard
deviations. Statistical comparison (unpaired t test) of MN8m versus JB17 gave a P
value of <0.001.
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Figure 27. PNAG production by the non-mucoid variant, JB17. PNAG slot blot
analysis of S. aureus strains producing different amounts of PNAG; probed with PNAGspecific polyclonal antiserum. Samples for both MN8m cell surface and spent media
were diluted 1:10 prior to immobilization on membrane.
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non-mucoid phenotype appeared to be mediating the variation through the loss of
detectable levels of PNAG, similar to the initial observations of the previously
characterized non-mucoid variant JB12, although not necessarily caused by the same
mechanism.

icaADBC transcript level of JB17
A 5 bp deletion in the icaADBC promoter region of MN8m is responsible for
constitutive icaADBC transcription and the constitutive hyper-production of PNAG that
characterizes strain MN8m (Jefferson et al., 2003). We sequenced this region of DNA in
strain JB17 and found that the 5 bp deletion was identical to MN8m. The icaADBC
genes are co-transcribed, so to determine levels of the full-length transcript, we
quantified levels of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in
Figure 28, icaADBC transcript levels were more than 300-fold greater in MN8m than in
the non-mucoid parent strain MN8 and the level remained elevated in the non-mucoid
variant JB17. These results indicate that the loss of PNAG production was not due to a
decrease in the level of icaADBC transcript, but rather that it was mediated by a
mechanism affecting PNAG synthesis.

Identification of a nonsense mutation in icaB of strain JB17
Since the 5 bp promoter deletion remained and there was no detectable
difference in icaADBC transcript levels, DNA sequencing of the entire operon was
performed. A deletion of two base pairs near the beginning of icaB was found (Fig. 29),
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Figure 28. Levels of ica transcript in the non-mucoid variant, JB17. Real-time RTPCR analysis of icaC mRNA transcript was performed. Bars represent the mean fold
difference in transcript amount relative to strain MN8 with n = 3, and error bars indicate
the standard deviations. Statistical comparison (unpaired t test) of MN8m and JB17
versus MN8 gave a P value of <0.001.
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causing a shift of translational reading frame and truncation of the protein; reducing
IcaB from 290 amino acids to 62.
However, previous work in our lab has shown that, while deletion of icaB
prevents surface association by preventing deacetylation of PNAG, it does not cause a
loss of PNAG production (Cerca et al., 2007). Instead, the PNAG is released into the
spent medium. Yet the PNAG slot blot of strain JB17 (Fig. 27), which was now known to
be an icaB mutant, did not show any PNAG present in the spent media. Therefore, we
hypothesized that the nonsense mutation in icaB might have a polar effect on the
expression of the downstream gene icaC, leading to the observed loss of PNAG
production. In our efforts to confirm that the nonsense mutation was responsible for loss
of the mucoid phenotype, we complemented the icaB gene in trans using the plasmid
pCL15. Given our hypothesis, we also complemented JB17 in trans with either icaBC,
icaC with the native Shine-Delgarno sequence intact, or icaC with the Shine-Delgarno
sequence modified to an ideal consensus sequence. Only expression of the intact
icaBC gene in strain JB17 from the IPTG-inducible plasmid pCL15 restored the mucoid
biofilm formation (Fig. 30) and PNAG synthesis (Fig. 31). Introduction of the empty
vector into the variant, or the other genes had no effect.

Discussion
We have isolated a non-mucoid variant from the mucoid strain MN8m that is
characterized by a loss of PNAG expression and biofilm formation. The mutation
responsible for the phenotype variation was shown to have no effect on icaADBC
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Figure 29. Schematic representation of the ica locus showing the position of the
nonsense mutation identified in icaB of the non-mucoid variant JB17. The
sequence highlighted in blue indicates icaB, the sequence highlighted in red indicates
icaC, and the overlapping region of these two genes is highlighted in purple.
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Figure 30. Effect of complementation in trans of JB17 with icaB, icaBC, or icaC
with native/modified ribosomal binding site on biofilm formation. Biofilms formed
in TSBG or TSBG+Cm+1mM IPTG on microtiter plate wells were stained with safranin
and the safranin was quantified by resuspending in acetic acid and measuring OD562 nm.
Bars represent the mean of 6 replicates, and error bars indicate the standard deviations.
Statistical comparison (unpaired t test) of JB17+pCL15 (empty vector) versus
JB17+pCL15-icaBC gave a P value of <0.001.
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Figure 31. Effect of complementation in trans of JB17 with icaB, icaBC, or icaC
with native/modified ribosomal binding site on PNAG production. PNAG slot blot of
cell surface fractions cultured in TSBG or TSBG+Cm+1mM IPTG probed with polyclonal
anti-PNAG antiserum (MN8m and JB17+pCL15-icaBC samples were diluted 1:10 prior
to immobilization on membrane whereas JB17 and the other JB17+pCL15 strains were
not diluted).
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transcript levels despite the absence of PNAG expression, and was identified as a 2-bp
deletion in icaB leading to a shift in translational reading frame (a nonsense mutation).
Since IcaB is responsible for partial deacetylation of PNAG polymers, allowing them to
remain surface associated, it is reasonable to expect an IcaB-negative mutant would
produce full-length highly-acetylated PNAG that is released into the supernatant. This
theory is supported by our previous work showing exactly this occurrence in S. aureus
in which the icaB gene was deleted through in-frame removal of approximately 80%
(Cerca et al., 2007). However, our work in this current study showed that the icaB
nonsense mutant strain JB17 produced no detectable PNAG, either on the cell surface
or in the culture supernatant. Additionally, complementation in trans of intact IcaB did
not restore any detectable production or surface expression of PNAG. These results
indicate that the use of the common techniques of creating a null mutant through allelic
replacement or deleting a majority of the gene but leaving the remaining portion in
frame, may have masked a previously unknown role of the icaB gene in the expression
of the PNAG synthesis pathway.
Polarity between multiple genes in a co-transcribed operon is very common in
prokaryotes, and is almost certainly relevant to these observations. IcaC is thought to
be responsible for assembly of full-length PNAG polymers within the cell and
translocating them to the cell surface, and is therefore considered an indispensable part
of the PNAG synthesis pathway. We therefore hypothesized that a nonsense mutation
early in icaB would have a polar effect on expression of icaC, leading to the loss of
function of both gene products. Our observations that icaC transcript levels are not
diminished by the mutation indicate that the polar effect does not alter transcription of
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the downstream gene, meaning that the effect is most likely through translational
coupling of the genes.
A specific nucleotide mutation is not in itself polar, instead the large region left
untranslated between the two genes is (Zipser, 1969). Mutational studies have
previously supported the importance of translation stopping at its normal site in close
proximity to the start of the distal gene. Altering translation termination closer to the
promoter increases the untranslated region and increases the polar effect, further
reducing translation of the downstream gene. This has been shown to be due to one of
the three models of translational coupling, all of which are dependent on ribosomes
translating the upstream gene coming into close physical proximity to the initiation site
of the downstream gene to either: relieve secondary structure occluding the start site, or
to ‘slide’ after pausing and reinitiate translation themselves because free ribosomes are
unable to recognize it. Our discovery that icaC complementation in trans did not restore
PNAG production or secretion into the supernatant, led us to investigate the possibility
that this last type of translational coupling was responsible for the JB17 phenotype. We
tested this theory by expressing a modified version of the icaC gene in trans. It was
modified by the replacement of the native ribosomal binding site with an optimized
Shine-Delgarno sequence, which we hypothesized would restore PNAG production into
the supernatant if poor binding of free ribosomes was responsible for the loss of
translation. However, we were able to conclude that optimizing the ribosomal binding
site of icaC so that it can be ‘seen’ by free ribosomes is not sufficient to restore PNAG
production. Therefore, it is still possible that mRNA secondary structure at the
translation initiation site of icaC is preventing translation because ribosomes translating
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icaB prematurely disassociate too far upstream, an effect which might still be observed
if the same base-pair structure is present in the mRNA originating from the plasmid
encoded copy of icaC during complementation. To this point, our investigation into this
phenomenon has thus supported a polar relationship between the genes icaB and icaC,
and begun to elucidate the potential for translational coupling although the exact nature
has yet to be fully defined.
Our work has also addressed a common observation in other examples of polar
mutations: the existence of two species of mRNA, both full-length versions and
shortened transcripts that terminate near the mutation site (Zipser, 1969). Real-time RTPCR analysis of icaADBC transcription utilized icaC primers that are seated well
downstream of the nonsense mutation in icaB, and showed no significant difference in
icaC transcript level indicating that full-length mRNA is the dominant species in this
particular example of polarity. A Northern blot could be used to more conclusively
determine whether both potential species of mRNA are present and at what level.
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CHAPTER 6
Conclusions and Future Perspectives

Although the role of PNAG in S. aureus biofilms is perhaps the most studied of
the potential adhesive molecules of the extracellular polymeric matrix, our knowledge is
incomplete. The goal of this project was to utilize a strain that over-produces PNAG to
better elucidate details of the expression and regulation of the icaADBC operon
responsible for PNAG synthesis. We sought first to better understand promoterregulator interactions and promoter characteristics that influence transcriptional
activation, and then to explore new evidence that PNAG expression can be modulated
by phase variation within a biofilm population to reduce its contribution.
The initial research focus of this project was to characterize the molecular
mechanism underlying the 5 bp deletion in the S. aureus MN8m ica promoter region
that is responsible for the conversion to mucoid PNAG hyper-production. We were able
to conclude that the deletion has no effect on the intrinsic curvature of what we
determined to be a linear region of DNA in the ica promoter. The deletion also has no
apparent effect on the binding affinity of the positive regulator SarA, despite the fact that
it disrupts a putative binding site. In the process of determining this lack of binding
perturbation, it was noted that there are multiple potential binding SarA binding sites in
the region selected and that binding of multiple proteins does occur in vitro. Therefore
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further work should be devoted to determining if any specific sequence or site is a
preferred binding sites within this region, which would help to provide insight into the
current debate over whether SarA targets a nucleotide consensus sequence or a
specific type of DNA structural topology for binding. Beyond these initial investigations
into the characteristics of the MN8m promoter, we have concluded that the promoter
deletion renders SarA no longer necessary for ica transcriptional activation. In this strain
background, SarA does not act as a positive regulator of the icaADBC operon as it
known to be; instead SarA functions as a negative regulator to inhibit transcriptional
activation.
In the process of working with strain MN8m we were given the opportunity to
explore a phenomenon casually observed by handling liquid MN8m cultures: the
frequent occurrence of what appeared to be a non-mucoid sub-population. This has led
us to truly novel discoveries about regulation and expression of PNAG. Most notably,
we have identified a novel mechanism for switching off PNAG production through the
slipped-strand mispairing-mediated inactivation of IcaC. In vitro, elevated production of
PNAG carried a fitness cost and consequently, PNAG-negative phase variants quickly
increased in number relative to PNAG over-expressers. IcaC appears to be the chosen
target for phase variation in PNAG production and loss of this protein appears to confer
a survival advantage under nutrient-poor conditions relative to the loss of the entire
operon, suggesting that the other proteins encoded within the ica locus could have
some other function. The next step from this point would be to confirm that these
remaining genes are in fact functional as we suppose by determining if the first two
steps of the PNAG synthesis involving icaAD are still occurring. This could be
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accomplished by detecting PNAG-precursors within the bacterial cell, and could also
provide information about the function of the transmembrane domain lost in the icaC
variation if short oligomers of PNAG versus full length polymers are found; i.e. does the
mutation affect assembly or translocation function of IcaC? Evidence of this mechanism
of phase variation in clinical isolates has supported the in vivo relevance of our
observations, although future work needs to be devoted to confirming the predicted
phenotype change resulting from variable repeats. Further pursuit of these variant
clinical isolates may have greater implications in virulence and disease manifestation.
While characterizing the non-mucoid variants isolated from MN8m that possess
icaC mutations, we identified a mutant that was phenotypically identical but had a
nonsense mutation further upstream in icaB. This mutant did not secrete full length
PNAG into the surrounding milieu, as previous icaB mutational studies suggested it
should. We concluded that our previous method of generating a null mutant had
prevented the observation of a polar relationship between icaB and its downstream
gene icaC, a relationship that was supported by restoration of PNAG expression
through complementation in trans with icaBC. There are different types of polar
mutation effects, one of which is translational coupling, which we believe is occurring in
this operon. The translation termination location is critical in instances of translational
coupling, and allelic exchange with an antibiotic cassette would have prevented this
polar effect when the ribosome translating the cassette read through it and paused near
the icaC initiation site, allowing it to then be translated. Our work modifying the ShineDelgarno sequence indicates that further work is needed to identify the exact
mechanism of translational coupling between these two genes, which could be

	
  

123	
  

accomplished by removing the untranslated distance in-frame from between the icaB
nonsense mutation and icaC and by exploring the possibility of mRNA secondary
structure at the beginning of icaC.
Given the clinical relevance of Staphylococcus aureus as an opportunistic
pathogen responsible for a large range of infections that affect numerous sites of the
human body, research into its expression and regulation of virulence factors could have
significant impact of our understanding of their role in disease and potential treatment
strategies. Poly-N-acetylglucosamine is a major component of the extracellular
polymeric matrix of S. aureus biofilms, and its increased expression is sometimes a
crucial step in the disease progression of biofilm-associated infections. PNAG is also
present on the cell surface even when cells are not part of a biofilm and plays an
important role in innate immune evasion, contributing to avoidance of
opsonophagocytosis and resistance to antimicrobial peptides. Therefore, having a more
complete basic scientific understanding of icaADBC expression and regulation could
potentially be very useful. The work in this study has identified multiple new levels of ica
expression regulation, including at the level of transcription through the activity of SarA,
of translation through polarity between icaB and icaC, and modulating PNAG
expression by direct nucleotide mutation resulting in phase variation. These
observations are significant because cutting-edge therapeutic strategies are currently
attempting to target virulence factors rather than viability. Anti-virulence therapies are
ideal because they are less likely to result in the propagation of mutations leading to
resistance since they exert less selective pressure upon the bacterial population.
Therefore, the contributions of this study to our understanding of the regulation of one of
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S. aureus’ key virulence factors may help to make future anti-virulence strategies more
effective.
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